Figure 1.
Cell viability assayed by MTT. Cell viability of HaCaT cells decreased significantly upon miR-184 siRNA treatment. Data expressed as mean ±SD (* P<0.05).
Cell viability assayed by MTT. Cell viability of HaCaT cells decreased significantly upon miR-184 siRNA treatment. Data expressed as mean ±SD (* P<0.05).